BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #911BiotechnologyInfectious Disease
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

BNTX at a glance

BNTX is priced at $80.96 right now, down 0.52% on the session. That puts its market value at $20.07B, 911th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($79.52 to $124.00), 34.7% under the high. Holders are behind 15.3% over twelve months, and down 28.2% across the last three months.

On the chart it has slipped under both the 50-day ($91.52) and 200-day ($95.09) moving averages; RSI is 31, and the last 30 sessions moved at roughly 36% annualized volatility.

In the quarter ended Sep 2026 the company brought in €1.29B of revenue, down 15.1% from a year earlier, with €184.50M of net profit (a -60.9% margin).

16 analysts follow the stock and the average call is "buy". The mean target, $119.33, sits 47.4% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$81.00 / $83.00
Average price today$80.93
Volume1.71MAvg (90d) 1.17M
Turnover$138.41M
Turnover rate1.61%of shares outstanding
Volume ratio1.47vs. recent average pace
Day amplitude3.19%
Market cap$20.07B
Float market cap$8.58B
Shares outstanding106.00M
EPS (TTM)-$5.15
P/B1.03
Book value / share$78.35
Net profit (TTM)-$1.28B
Net assets$19.42B
30-day volatility35.9%annualized
Avg daily range (ATR)3.31%of price, 14 days
Max drawdown (1y)-32.2%-32.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

16 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 36.6 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth50.4
Profitability25.3
Momentum21.0
Financial health85.9
Analyst view62.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$119.33+47.4% vs. current price
Consensus ratingBuy16 analysts covering
Morningstar fair value$76.00Price is above fair value

Wall Street’s average 12-month target is $119.33, 47.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $76.00, so shares trade 6.5% above that estimate. On earnings multiple, it sits in the 44th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-0.5%
1 week
-5.4%
1 month
-9.7%
3 months
-28.2%
6 months
-12.1%
Year to date
-15.0%
1 year
-15.3%
Day range
$80.27$82.87
52-week range
$79.52$124.00

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-6.2%Bearish
Price vs 50-day average-11.5%Bearish
Price vs 200-day average-14.9%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)31.5Bearish
MACD (12,26,9)-2.50Bearish
Bollinger band position-6%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How BNTX ranks on BeStock

Market value#910 of 3734
Closeness to 52-week high#2432 of 3724
Dollar volume today#827 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

BNTX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on BNTX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on BNTX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

BNTX stock: common questions

How is BioNTech stock doing today?

$80.96 is the latest print for BNTX, a move of -0.52% against yesterday's close of $81.38. Today's low and high so far: $80.27 and $82.87.

How big is BioNTech?

Equity value comes to $20.07B at the current price. By that measure it is number 911 of the 3753 names in our coverage.

Is BNTX near its 52-week high or low?

The year's floor is $79.52 and the ceiling $124.00. Shares are 34.7% away from that ceiling.

Does BioNTech pay a dividend?

Our data shows no dividend paid by BioNTech over the trailing twelve months.

Is BNTX rated a buy by Wall Street?

Of 16 analysts, 75% say buy, 25% hold and 0% sell. Price targets average $119.33, with the most cautious at $93.00 and the most optimistic at $140.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on BNTX.

Sign in to join the discussion.

Scroll to Top